| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $53.4M | +110.5% |
| R&D Expense | $38.3M | -72.1% |
| SG&A Expense | $66.9M | +5.6% |
| Operating Income | -$55.6M | +68.6% |
| Income Tax | $0 | — |
| Net Income | -$52.5M | +69.1% |
| EPS (Basic) | -$0.30 | +79.0% |
| EPS (Diluted) | -$0.30 | +79.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $226.7M | +226.9% |
| Accounts Receivable | $13.9M | +27.6% |
| Current Assets | $247.5M | +145.8% |
| Total Assets | $276.9M | +113.8% |
| Current Liabilities | $34.2M | -44.9% |
| Total Liabilities | $35.3M | -43.0% |
| Stockholders' Equity | $241.5M | +257.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.1M | +65.9% |
| Capital Expenditures | $155K | +10.7% |
| Investing Cash Flow | -$155K | -10.7% |
| Financing Cash Flow | $215.6M | +448.2% |
| Free Cash Flow | -$58.3M | +65.8% |